Total Payments
$15,998
2024 Payments
$2,811
Companies
34
Transactions
343
Medicare Patients
301
Medicare Billing
$21,400
Payment Breakdown by Category
Other$9,495 (59.4%)
Food & Beverage$5,899 (36.9%)
Travel$303.85 (1.9%)
Consulting$300.00 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,495 | 9 | 59.4% |
| Food and Beverage | $5,899 | 329 | 36.9% |
| Travel and Lodging | $303.85 | 3 | 1.9% |
| Consulting Fee | $300.00 | 2 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $10,202 | 25 | $0 (2022) |
| ABBVIE INC. | $887.64 | 75 | $0 (2024) |
| Eisai Inc. | $476.52 | 28 | $0 (2024) |
| Lilly USA, LLC | $455.36 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $436.82 | 21 | $0 (2024) |
| Biogen, Inc. | $422.27 | 10 | $0 (2024) |
| EMD Serono, Inc. | $334.57 | 20 | $0 (2024) |
| Lundbeck LLC | $301.29 | 15 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $291.20 | 16 | $0 (2024) |
| Neurelis, Inc. | $216.15 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,811 | 158 | ABBVIE INC. ($651.71) |
| 2023 | $2,340 | 125 | Novartis Pharmaceuticals Corporation ($219.73) |
| 2022 | $10,664 | 57 | Biohaven Pharmaceutical Holding Company Ltd. ($10,202) |
| 2021 | $183.58 | 3 | Biogen, Inc. ($150.00) |
All Payment Transactions
343 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: EPILEPSY | ||||||
| 12/17/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $32.06 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Central Nervous System | ||||||
| 12/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $29.92 | General |
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug), VYVGART | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: Neurology | ||||||
| 11/25/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Neurology | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.32 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Neurology | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: PAIN | ||||||
| 11/13/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $28.19 | General |
| Category: NEUROLOGY | ||||||
| 11/07/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $34.69 | General |
| Category: Neurology | ||||||
| 11/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Neuroscience | ||||||
| 10/23/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: EPILEPSY | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $34.87 | General |
| Category: Neurology | ||||||
| 10/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $7.10 | General |
| Category: NEUROLOGY | ||||||
| 10/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 39 | 46 | $13,210 | $3,208 |
| 2021 | 1 | 72 | 79 | $20,825 | $5,242 |
| 2020 | 3 | 190 | 261 | $58,839 | $12,950 |
Total Patients
301
Total Services
386
Medicare Billing
$21,400
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 30 | $9,690 | $2,399 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 16 | $3,520 | $809.29 | 23.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 35 | $9,649 | $2,727 | 28.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 40 | 44 | $11,176 | $2,515 | 22.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 78 | 123 | $31,242 | $6,261 | 20.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 43 | 56 | $14,224 | $3,706 | 26.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 26 | 38 | $6,384 | $1,162 | 18.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 13 | $2,184 | $652.27 | 29.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 20 | 20 | $3,100 | $649.17 | 20.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 11 | 11 | $1,705 | $519.10 | 30.4% |
About Kelly Cox
Kelly Cox is a Acute Care healthcare provider based in Jacksonville Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/21/2014. The National Provider Identifier (NPI) number assigned to this provider is 1275937179.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kelly Cox has received a total of $15,998 in payments from pharmaceutical and medical device companies, with $2,811 received in 2024. These payments were reported across 343 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,495).
As a Medicare-enrolled provider, Cox has provided services to 301 Medicare beneficiaries, totaling 386 services with total Medicare billing of $21,400. Data is available for 3 years (2020–2022), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Other Specialties Adult Health
- Location Jacksonville Beach, FL
- Active Since 10/21/2014
- Last Updated 09/23/2024
- Taxonomy Code 363LA2100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275937179
Products in Payments
- NURTEC ODT (Drug) $10,381
- UBRELVY (Drug) $780.54
- Leqembi (Drug) $433.39
- KESIMPTA (Drug) $418.32
- TYSABRI (Biological) $381.47
- VYEPTI (Biological) $301.29
- AMYVID (Drug) $286.39
- VALTOCO (Drug) $216.15
- Trudhesa (Drug) $184.17
- REXULTI (Drug) $183.22
- Aimovig (Biological) $163.40
- EMGALITY (Drug) $150.00
- NUPLAZID (Drug) $128.92
- UPLIZNA (Drug) $122.40
- MAVENCLAD (Drug) $122.15
- AJOVY (Biological) $112.94
- NUEDEXTA (Drug) $107.98
- QULIPTA (Drug) $107.10
- VYVGART HYTRULO (Drug) $107.08
- Ocrevus (Biological) $106.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.